Announcements Trials
Browse Landscape

Phase

Phase NA 44Phase 2 3Phase 4 2Phase 3 2Phase EARLY_PHASE1 1Phase 1 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 4Thoracic 2Gastrointestinal 2Sarcoma 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Sarcoma 1Pancreatic Neoplasms 1Neoplasms 1Lung Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Airway Obstruction 1

Interventions

Carboplatin 283Cisplatin 225Pemetrexed 196Paclitaxel 151Docetaxel 132pembrolizumab 109Gemcitabine 94Etoposide 64Erlotinib Hydrochloride 59Radiotherapy 54Vinorelbine 47durvalumab 46Gefitinib 46Bevacizumab 46atezolizumab 42Nivolumab 40Drug Therapy 34osimertinib 30Topotecan 29tislelizumab 23130-nm albumin-bound paclitaxel 23Radiosurgery 21Ipilimumab 18Crizotinib 18Magnetic Resonance Spectroscopy 15Albumin-Bound Paclitaxel 15Surgical Procedures, Operative 14aumolertinib 13Platinum 13Injections 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Blood Specimen Collection × Thoracic × Clear all
NCT06332274 2025-05-13

UMBRELLA

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Recruiting
717 enrolled
GastrointestinalSarcomaThoracic

Colonic Neoplasms, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Sarcoma

NCT01003522 2009-10-28

RESTORE-AIR

Royal Marsden NHS Foundation Trust

Phase 3 Unknown
60 enrolled
Thoracic

Airway Obstruction, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡